Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice

被引:70
作者
Schwarz, HP
Lenting, PJ
Binder, B
Mihaly, J
Denis, C
Dorner, F
Turecek, PL
机构
[1] Baxter Hyland Immuno, A-1221 Vienna, Austria
[2] Univ Vienna, Vienna, Austria
[3] Harvard Univ, Ctr Blood Res, Boston, MA 02115 USA
[4] CLB, Dept Plasma Prot Technol, Amsterdam, Netherlands
关键词
D O I
10.1182/blood.V95.5.1703.005k20_1703_1708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIII is tightly noncovalently linked to von Willebrand factor (vWF) in plasma with a stoichiometry of 1:50, and vWF deficiency results in secondary factor VIII deficiency, with accelerated clearance of factor VIII from the circulation, We used a murine model of severe von Willebrand disease (vWF knockout mice) to study the effect of a recombinant vWF/pro-vWF preparation (rpvWF) on factor VIII survival and to investigate whether low-density lipoprotein receptor-related protein (LRP) might be involved in the in vivo clearance of factor VIII in the absence of vWF, vWf deficient mice received 70 U/kg rpvWF in the first series of experiments, and in a second series, 80 mg/kg receptor-associated protein (RAP) as a recombinant fusion protein to block the action of LRP. Factor VIII levels were measured at time 0, or 1 or 3 hours after administration of rpvWF or RAP. RAP induced a sustained rise in factor VIII levels comparable to that induced by rpvWF, In a third series, the preadministration of RAP resulted in a slower disappearance of factor VIII antigen (measured by an enzyme-linked immunosorbent assay specific for human factor VIII) after infusion of recombinant factor VIII, These findings suggest that the accelerated clearance of factor VIII seen in the absence of vWF may be a result of the involvement of LRP in factor VIII metabolism. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1703 / 1708
页数:6
相关论文
共 49 条
[11]  
GRUBER A, 1992, BLOOD, V79, P2340
[12]  
HERZ J, 1991, J BIOL CHEM, V266, P21232
[13]   EVIDENCE THAT NH2-TERMINAL BUT NOT COOH-TERMINAL MOIETY OF PLASMA VON WILLEBRAND FACTOR BINDS TO FACTOR-VIII [J].
JORIEUX, S ;
MAGALLON, T ;
MAZURIER, C .
THROMBOSIS RESEARCH, 1987, 48 (02) :205-210
[14]   von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver [J].
Kaufman, RJ ;
Dorner, AJ ;
Fass, DN .
BLOOD, 1999, 93 (01) :193-197
[15]   INACTIVATION OF HUMAN FACTOR-VIII BY ACTIVATED PROTEIN-C - COFACTOR ACTIVITY OF PROTEIN-S AND PROTECTIVE EFFECT OF VONWILLEBRAND-FACTOR [J].
KOEDAM, JA ;
MEIJERS, JCM ;
SIXMA, JJ ;
BOUMA, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1236-1243
[16]   THE EFFECT OF VONWILLEBRAND-FACTOR ON ACTIVATION OF FACTOR-VIII BY FACTOR-XA [J].
KOEDAM, JA ;
HAMER, RJ ;
BEESERVISSER, NH ;
BOUMA, BN ;
SIXMA, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 189 (02) :229-234
[17]   Requirements of von willebrand factor to protect factor VIII from inactivation by activated protein C [J].
Koppelman, SJ ;
vanHoeij, M ;
Vink, T ;
Lankhof, H ;
Schiphorst, ME ;
Damas, C ;
Vlot, AJ ;
Wise, R ;
Bouma, BN ;
Sixma, JJ .
BLOOD, 1996, 87 (06) :2292-2300
[18]  
LANG H, 1991, THROMB HAEMOSTASIS, V65, P943
[19]   The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein [J].
Lenting, PJ ;
Neels, JG ;
van den Berg, BMM ;
Clijsters, PPFM ;
Meijerman, DWE ;
Pannekoek, H ;
van Mourik, JA ;
Mertens, K ;
van Zonneveld, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23734-23739
[20]   The life cycle of coagulation factor VIII in view of its structure and function [J].
Lenting, PJ ;
van Mourik, JA ;
Mertens, K .
BLOOD, 1998, 92 (11) :3983-3996